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Quality indicators of diabetes care:
an example of remote-area Aboriginal
primary health care over 10 years
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Far North Queensland following the
introduction of the “Meriba Zageth
for diabetes” plan.6
Derby is a small remote Western
Australian town with a harsh seasonal
climate, 230 km from the regional
centre of Broome and 2350 km from
Perth tertiary referral centres. The
2006 census rated the Derby–West
Kimberley area as the fifth most disadvantaged in Western Australia.7
Recruitment and retention of skilled
professionals in Derby is a constant
challenge, with a number of key local
services characterised by high staff
turnover. Derby Aboriginal Health
Service (DAHS) is an Aboriginal community-controlled health service that
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Abstract
Objectives: To describe service characteristics of Derby Aboriginal Health Service
(DAHS) and document diabetes management activities and intermediate clinical
outcomes for Aboriginal patients with type 2 diabetes.
Design, setting and patients: Retrospective audit of records for patients  15
years old who had a confirmed diagnosis of type 2 diabetes, received primary
health care from DAHS for at least 6 continuous months between 1 July 1999 and
30 June 2009, resided in the Derby area and were not on renal replacement
therapy.
Main outcome measures: Electronic records of blood pressure (BP), glycated
haemoglobin (HbA1c) level, weight, albumin–creatinine ratio, creatinine level or
estimated glomerular filtration rate, lipid levels and smoking status during each
audit year; and proportions of patients who met clinical targets for HbA1c, BP
and cholesterol.
Results: Over the 10 years, the proportion of clinical care activities undertaken
according to regional protocols increased significantly, with very high levels
recorded in the last 3 years (at least 70% of patients had each activity recorded).
There were significant improvements in systolic BP, diastolic BP and cholesterol
levels over the 10 years (P < 0.001 for all). In the final year, 69% of patients had at
least half their BP measurements  130/80 mmHg and 83% had median annual
cholesterol levels of < 5.5 mmol/L. There were small improvements in HbA1c
levels that approached statistical significance (P = 0.05). In the final year, 34%
of patients had median annual HbA1c levels of  7.0%.
Conclusions: This study shows that diabetes monitoring and outcomes can be
improved and maintained over a 10-year period in a well supported remote
Aboriginal community-controlled health service setting.

cal outcomes for DAHS Aboriginal
and Torres Strait Islander patients
with type 2 diabetes.

Methods
This study covers 10 audit years, from
1 July 1999 to 30 June 2009. It includes
Aboriginal and Torres Strait Islander
patients seen at DAHS who had type
2 diabetes mellitus, were  15 years
old, received primary care from DAHS
for at least 6 continuous months, lived
in or near Derby, and were not on
renal replacement therapy.
The final study population was
determined by carrying out a comprehensive retrospective review of paper
and electronic records. During review
of these records, the date of diagnosis
of diabetes for each patient was confirmed as far as possible.

into Project Ferret (Pen Computer
Systems), a patient information and
recall system, were corrected. From
2007, data entry was monitored more
closely. At the end of 2009, data were
extracted from Project Ferret and
transferred into Excel 2003 (Microsoft). Outliers were identified and
data entry errors were corrected.
Fewer electronic creatinine results
than expected were observed during
the audit years 2005–06 and 2006–07
and further corrections, based on
paper records, were made. The data
were then imported into Stata, version 11 (StataCorp).
Service characteristics

The major activities and factors likely
to have had a direct impact on the
quality of care provided to patients
with diabetes at DAHS are listed in
Box 1.

Data extraction and cleaning

In 2007, DAHS staff checked the
accuracy of patients’ electronic
records against paper records. Results
incorrectly recorded or not entered

Quality indicators of diabetes care

The occurrence of activities relating to
diabetes management was assessed
over the 10 audit years. Measures

Research
Results

1 Major activities and factors likely to have directly affected quality of care
provided by DAHS to patients with diabetes, 1999–2009

•

Aboriginal community-controlled health service, with stable governance by
community-elected board of directors and executive managers

•

After operating in the early stages on a limited start-up budget, DAHS secured a
purpose-built facility in 2005 and has drawn incrementally increasing resources to
support service growth and diversification in response to demand

•

Electronic health information systems:
 in addition to paper records, a patient information and recall system (Project
Ferret) was used to capture key clinical data; it was also used for reporting and
CQI purposes
 data entry clerk changed infrequently, ensuring consistency over time

•
•

Significant consistency of senior staff

•

Formal and informal teaching and upskilling incorporated into routine practice:
 medical students hosted for their penultimate year, general practice registrar
training, junior doctor placements, Aboriginal health worker student placements
and nursing student placements

•

CQI approaches based on a culture of organisational appraisal and improvement,
encouraging review and reflection by staff at all levels, and embracing change in
response to identified gaps

•

Formalised CQI processes included:
 brief participation in the Australian Primary Care Collaboratives program8 and
the Audit and Best Practice for Chronic Disease project9
 ongoing internal and external (Kimberley Aboriginal Medical Services Council)
audit of service data
 formalisation of regular audit process during the 2006–07 audit year, by
introducing an internally developed standardised audit tool and routine audit
process

•

Regional support and standardisation of systems:
 part of a regional collective of Aboriginal community-controlled health services
 development and implementation across health sectors of the Kimberley
Standard Drug List and evidence-based Kimberley Chronic Disease Therapeutic
Protocols10

Specialist outreach services, including visiting general physicians, dietitians,
podiatrists and diabetes educators

DAHS = Derby Aboriginal Health Service. CQI = continuous quality improvement.

◆

expected to be recorded at least 6
monthly (blood pressure [BP], glycated haemoglobin [HbA1c] level,
weight) were assessed over the last 6
months of each audit year (1 January
to 30 June). Measures expected to be
recorded annually (albumin–creatinine ratio [ACR], creatinine level or
estimated glomerular filtration rate
[eGFR], lipid levels, smoking status)
were assessed over the full audit year.

half their electronic measurements
meeting both targets were determined for each audit year.
Patients were classified as having
proteinuria and/or kidney disease if
they had at least two ACR results
> 3.6 mg/mmol without obvious infection, creatinine or eGFR results suggestive of chronic kidney disease,10
and/or were assigned to a proteinuria
or chronic kidney disease care plan.

Clinical outcome measures

Statistical analysis

Clinical outcome measures were
assessed each audit year. Overall
median HbA1c and cholesterol levels
were determined using medians for
individual patients during each audit
year. Also, the proportions of
patients with median HbA1c and
cholesterol levels meeting recommended targets11 were determined
for each audit year. As the recommended target for BP includes meeting the target for both systolic
( 130 mmHg) and diastolic
( 80 mmHg) measurements, the
proportions of patients with at least

A non-parametric test for trend across
ordered groups was used to assess
trend over time.12 Analyses were performed using Stata, version 12 (StataCorp). P < 0.05 was considered
statistically significant.
Ethics approval

Ethics approval was obtained from the
Western Australian Aboriginal Health
Information and Ethics Committee
and exemption from ethics review was
obtained from the Human Research
Ethics Committee of the University of
Western Australia.

After identifying 517 patients with
results suggestive of diabetes, 263
were excluded for not meeting the
selection criteria (Box 2). Participants
who commenced renal replacement
therapy, stopped receiving primary
care from DAHS or died were not
included after these events occurred.
The final study population of 254
patients contributed a total of 1502
patient-years of care. Of this patient
population, 107 (42%) were diagnosed after becoming a regular
patient at DAHS, 195 (77%) regularly
attended DAHS (as determined by the
clinic) from when they entered the
study until they were excluded or the
study finished, 166 (65%) were
included in at least 5 audit years, 35
(14%) were included in all 10 years
and 45 (18%) were included in both
the first and last years. The median
age of patients at the time of entering
the study was 46 years (range, 15–84
years); 159 patients (63%) were
female, 185 (73%) had or developed
proteinuria and/or kidney disease, 12
(5%) commenced renal replacement
therapy and 41 (16%) died.
Service activity for BP, HbA 1c,
weight, ACR, creatinine level or
eGFR, lipid levels and smoking status
increased significantly over time
(P  0.002 for trend over 10 years; Box
3). Median annual systolic and diastolic BP values and cholesterol levels
decreased significantly over time
(P  0.001 for trend over 10 years; Box 4).
The proportion of patients who met
currently recommended targets11 for
median annual cholesterol and who
had at least half their recorded results
for BP  130/80 mmHg also significantly increased over time (P  0.001
for trend over 10 years; Box 4).
Improvements in glycaemic control
over time approached statistical significance (P = 0.05 for trend over 10
years; Box 4). In the last year of the
study, the proportions of patients who
met the old targets of HbA1c < 7.0%
and BP < 130/80 mmHg were 33%
and 53%, respectively. Previously
reported data on care quality indicators and clinical outcome measures
relating to diabetes care in other Australian populations are included in
Box 3 and Box 4, respectively.1,6,8,9,13-19
MJA 197 (7) · 1 October 2012
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2 Selection process used to determine DAHS study population
517 patients  15 years old who had attended DAHS
from 1 July 1999 to 30 June 2009 were identified as
having results suggestive of diabetes, indicated by one
or more of the following
• on a diabetes care plan
• diagnosis of diabetes on paper records
• taking hypoglycaemic medication
• fasting plasma glucose level  7.0 mmol/L
• random plasma glucose level  11.1 mmol/L

100 patients did not have confirmed type 2 diabetes
• 31 did not have diabetes
• 67 had only one abnormal test result relating to diabetes and had
not been formally diagnosed
• 2 had type 1 diabetes

417 patients had confirmed type 2 diabetes

143 patients did not receive regular care
• 78 received primary care elsewhere
• 57 were visitors and not Derby area residents
• 8 received < 6 months care from DAHS after being diagnosed
with diabetes

274 patients had confirmed type 2 diabetes and were
regular DAHS patients

20 patients were excluded from the study for other reasons
• 17 were not Indigenous Australians
• 3 commenced RRT before being diagnosed with diabetes

254 patients were included in the study
DAHS = Derby Aboriginal Health Service. RRT = renal replacement therapy.

Discussion
To our knowledge, this is the first
published Australian study looking at
10 years of diabetes management in
primary care at an individual health
service. We showed significant and
sustained improvements in health
monitoring and intermediate outcomes at DAHS.
Improved care processes, improved
control of BP and prevention of complications that result in hospitalisation
have previously been demonstrated in
Aboriginal community-controlled
health services over short periods
when adequate clinical support and
appropriate management structures
have been provided.2,13
The main strength of our study is
that we used all recorded results for
patients over a 10-year period and
analysed clinical outcomes according
to clinical targets from current guide406
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lines.11 Comparisons can be made
with other studies, but caution is
required because of the different
methods and clinical targets used. The
Australian Primary Care Collaboratives program operates through
“waves” of 20–200 practices working
together over 18 months,8 while the
Audit and Best Practice for Chronic
Disease project randomly selected 30
patients with diabetes from each of 62
services and used the most recent
value for each patient within 12
months of the audit.9 The currently
recommended target for BP is  130/
80 mmHg,11 but previously it was
< 130/80 mmHg. In our study, this
meant that the proportion of patients
with BP complying with target values
changed from 53% to 69% in the final
year. Similar changes occurred in the
Australian National Diabetes Audit
and Benchmarking project (54% of
patients with BP  130/80 mmHg in

2009 compared with 38% of patients
with BP < 130/80 mmHg in 2006).17,20
The change in HbA1c target (< 7.0%
to  7.0%) made less difference in our
study (33% v 34% of patients meeting
the respective targets in the final
year).
Limitations of this study included
underrecording. In the earlier years,
this may have contributed to the
trend of improvements over time. As
part of the CQI processes at DAHS,
staff checked the accuracy of the
measures reported in this article and
updated electronic records, but some
bias due to underrecording in the
earlier years is likely. Our data on the
duration of diabetes may also be
biased because of difficulties in determining when diabetes was diagnosed
in patients who were diagnosed at
other health services. This study was
also limited to data that were available; important outcomes, such as hospital admissions and medication
usage, were not recorded electronically and more sophisticated measures relating to quality of life were not
collected.
Our results compare well with
those of other Australian studies of
patients with diabetes. In terms of the
intermediate outcome measures that
we examined, BP was better controlled than in other Australian studies,
including mainstream general practice studies (69% v 28%–54%8,16,17),
and cholesterol levels were similar or
better (83% v 53%–86%9,15-19). Glycaemic control was near the best
reported in Indigenous Australian
studies (34% v 22%–32%1,6,9,14,15) but
not as good as has been reported in
studies of mainstream general practice (37%–57%).8,18,19
Despite the improvements we have
shown, there is substantial room for
further improvements in clinical outcomes. The focus on preventing or
delaying kidney failure in the Kimberley may partly explain why BP control
was particularly good in this study.
Glycaemic control is considered more
difficult to achieve compared with
other measures 6 and only small
improvements in glycaemic control
were evident in this study, although
even small improvements can be clinically useful. Further investigation is
planned to model HbA1c measurements over time for individuals and
determine factors that are likely to

Research
3 Proportions of DAHS study population for whom diabetes management activities were recorded in the electronic patient and information recall
system during the 10 audit years, and corresponding values from the final years of other studies
Audit year
1999
–00

2000
–01

2001
–02

2002
–03

2003
–04

2004
–05

2005
–06

2006
–07

2007
–08

2008
–09

582

816

603

699

808

982

943

1232

1349

1227

No. of patients included in study

80

129

136

136

164

176

172

172

177

173

Median time since diagnosis, at 30 June (years)

1.3

2.2

3.0

4.0

4.4

5.4

6.0

6.8

7.5

8.5

Total no. of patients‡

P*

Indigenous
Australians,
PHC†

Proportion of patients for whom activity was recorded
Blood pressure§

74%

77%

64%

71%

75%

74%

74%

81%

82%

80%

0.002

65%–83%

HbA1c§

53%

60%

68%

66%

69%

66%

72%

75%

70%

74%

< 0.001

56%–73%

Weight§

53%

58%

49%

45%

64%

61%

65%

75%

79%

74%

< 0.001

51%–74%

Albumin–creatinine ratio¶

45%

47%

51%

54%

77%

67%

65%

77%

79%

81%

< 0.001

50%–83%

Creatinine level or eGFR¶

68%

74%

72%

85%

83%

80%

75%

87%

87%

94%

< 0.001

69%–86%

Lipid levels¶

56%

62%

53%

67%

72%

68%

70%

80%

79%

91%

< 0.001

52%–88%

Smoking status¶

11%

45%

14%

48%

60%

49%

38%

70%

80%

85%

< 0.001

24%

0

19%

6%

14%

29%

22%

18%

47%

47%

50%

< 0.001

2.9

4.2

3.6

4.1

4.9

4.3

4.3

5.3

5.4

5.5

< 0.001

All seven activities
Mean no. of activities recorded

DAHS = Derby Aboriginal Health Service. PHC = primary health care. HbA1c = glycated haemoglobin. eGFR = estimated glomerular ﬁltration rate. * For trend over 10 years. † Australian
Aboriginal and Torres Strait Islander patients treated in PHC settings.1,9,13,14 ‡ All DAHS patients 15 years of age who had at least one electronic blood pressure or weight measurement
recorded. § Process recorded from 1 January to 30 June during each audit year. ¶ Process recorded from 1 July to 30 June during each audit year.
◆

contribute to individuals attaining and
maintaining good glycaemic control.
From 2012, reporting of national
key performance indicators (nKPIs) is
a requirement for Aboriginal community-controlled health services under
the National Indigenous Reform
Agreement.21 The nKPIs include the
HbA1c and BP measures for patients
with diabetes that we included in our
study. It is hoped that the use of
nKPIs will result in comparable data
from Aboriginal health services being
produced.
Over the decade covered by our
study, a number of policy changes
were introduced at a national level
which may have had an enabling

role for DAHS in chronic disease
care for its patients. These include
the introduction of Medicare reimbursement for comprehensive Aboriginal and Torres Strait Islander
preventive health checks and for
chronic disease management planning and follow-up,22 and access to
medications at low or no cost for
Aboriginal people in remote areas
(section 100 of the National Health
Act 1953 [Cwlth]).23
DAHS had regular changes in
health staff and management, but it
also had significant consistency in
senior staff over the decade we studied. The service also had improving
resources over the study period,

although resourcing started from a
low base. DAHS maintained its community connections with a consistent
board of directors, long-term employment of Aboriginal health workers
and nurses, and a focus on genuine
comprehensive primary health care
for its patients.
Sustainability of chronic disease
programs has previously been
reported to be a major challenge in
remote Aboriginal and Torres Strait
Islander health settings.24 This study
shows that diabetes monitoring and
outcomes can be improved and maintained over a 10-year period in a
remote Aboriginal community-controlled health service setting.

4 Clinical outcome measures of DAHS study population and proportions of those with outcome values that met currently recommended targets during
the 10 audit years, and corresponding values from the final years of other studies
Audit year
1999
–00

2000
–01

2001
–02

2002
–03

2003
–04

2004
–05

2005
–06

2006
–07

2007
–08

2008
–09

P*

Indigenous
Australians, Australians, Australians,
secondary‡
PHC§
PHC†

Median annual clinical outcome measures
Systolic BP (mmHg)

135

134

130

128

124

120

120

120

120

120

< 0.001

128–130

130

Diastolic BP (mmHg)

85

80

81

80

80

80

78

75

74

75

< 0.001

78–80

75

78

HbA1c (%, mmol/mol)

8.2, 66

8.7, 72

8.2, 66

7.7, 61

8.1, 65

8.3, 67

0.05

8.1–9.0

7.9

6.8–7.4

Cholesterol (mmol/L)

5.0

5.0

5.1

4.9

5.0

4.9

4.6

4.7–5.0

4.3

4.7

8.1, 65 8.0, 64 7.6, 60 8.0, 64
4.7

4.6

4.5

< 0.001

134

Proportion of study population with median values that met targets
BP  130/80 mmHg¶

38%

46%

44%

53%

66%

66%

67%

75%

70%

69%

< 0.001

HbA1c  7.0% ( 53 mmol/mol)

26%

28%

34%

34%

31%

24%

32%

36%

39%

34%

0.05

22%–32%
29%

28%–54%

34%

30%–32%

37%–57%

Cholesterol < 4.0 mmol/L**

4%

12%

8%

22%

16%

18%

16%

21%

24%

25%

< 0.001

Cholesterol < 5.5 mmol/L††

64%

63%

71%

76%

73%

72%

76%

75%

81%

83%

< 0.001 65%–79% 80%–86% 53%–85%

DAHS = Derby Aboriginal Health Service. PHC = primary health care. BP = blood pressure. HbA1c = glycated haemoglobin. * For trend over 10 years. † Australian Aboriginal and
Torres Strait Islander patients treated in PHC settings.1,6,9,14,15 ‡ General Australian population treated in secondary care settings.16,17 § General Australian population treated in
mainstream general practice settings.8,18,19 ¶ At least half of each participant’s recorded measurements met the recommended target for both systolic and diastolic BP.
** Recommended for people with diabetes.11 †† Recommended for the general population.

MJA 197 (7) · 1 October 2012

22%

◆

407

Research
Acknowledgements: This study was initiated and
funded by DAHS as part of their CQI program, with in-kind
contributions including independent analysis by the Rural
Clinical School of WA, at the University of Western Australia, and the Kimberley Aboriginal Medical Services
Council. We had full access to all the data (including
statistical reports and tables) in the study. We thank staff
at DAHS for their efforts in cleaning up the database used
in this study. We thank Max Bulsara and Sharon Evans for
expert statistical advice and Sophie Couzos and Ian Ring
for critical reading of this article.
Competing interests: Carmel Nelson was the Senior
Medical Officer (from 1999 to 2005) at DAHS. Vicki
O’Donnell is the Chief Executive Officer (from 2002 to
present) of DAHS.

7

8

9

Received 9 Feb 2012, accepted 22 Aug 2012.
1 McDermott RA, Schmidt BA, Sinha A, Mills P.

2

3

4

5

6

408

Improving diabetes care in the primary
healthcare setting: a randomised cluster trial in
remote Indigenous communities. Med J Aust
2001; 174: 497-502.
Si D, Bailie RS, Togni SJ, et al. Aboriginal health
workers and diabetes care in remote community
health centres: a mixed method analysis. Med J
Aust 2006; 185: 40-45.
Holman RR, Paul SK, Bethel MA, et al. 10-year
follow-up of intensive glucose control in type 2
diabetes. N Engl J Med 2008; 359: 1577-1589.
Stratton IM, Adler AI, Neil HA, et al. Association of
glycaemia with macrovascular and microvascular
complications of type 2 diabetes (UKPDS 35):
prospective observational study. BMJ 2000; 321:
405-412.
Mundet X, Cano F, Mata-Cases M, et al. Trends in
chronic complications of type 2 diabetic patients
from Spanish primary health care centres
(GEDAPS study): ten year-implementation of St
Vincent recommendations. Prim Care Diabetes
2012; 6: 11-18.
McDermott RA, McCulloch BG, Campbell SK,
Young DM. Diabetes in the Torres Strait Islands of
Australia: better clinical systems but significant
increase in weight and other risk conditions

MJA 197 (7) · 1 October 2012

10

11

12
13

14

15

among adults, 1999-2005. Med J Aust 2007; 186:
505-508.
Australian Bureau of Statistics, Australian
Institute of Health and Welfare. The health and
welfare of Australia’s Aboriginal and Torres Strait
Islander peoples 2005. Canberra: AIHW, 2005.
(AIHW Cat. No. IHW 14.) http://www.aihw.gov.
au/publication-detail/?id=6442467754
(accessed Aug 2012).
Ford DR, Knight AW. The Australian Primary Care
Collaboratives: an Australian general practice
success story. Med J Aust 2010; 193: 90-91.
Si D, Bailie R, Dowden M, et al. Assessing quality
of diabetes care and its variation in Aboriginal
community health centres in Australia. Diabetes
Metab Res Rev 2010; 26: 464-473.
Kimberley Aboriginal Medical Services Council,
WA Country Health Service Kimberley. Kimberley
chronic disease protocols. 2010. http://
resources.kamsc.org.au/c_k_d_protocols.html
(accessed Aug 2012).
Diabetes Australia, Royal Australian College of
General Practitioners. Diabetes management in
general practice. 17th ed. Melbourne: Diabetes
Australia, 2011. http://www.racgp.org.au/
Content/NavigationMenu/ClinicalResources/
RACGPGuidelines/Diabetesmanagement/
201107diabetesmanagementingeneralpractice.
pdf (accessed Jun 2012).
Cuzick J. A Wilcoxon-type test for trend. Stat Med
1985; 4: 87-90.
McDermott R, Tulip F, Schmidt B, Sinha A.
Sustaining better diabetes care in remote
Indigenous Australian communities. BMJ 2003;
327: 428-430.
Bailie RS, Si D, Robinson GW, et al. A multifaceted
health-service intervention in remote Aboriginal
communities: 3-year follow-up of the impact on
diabetes care. Med J Aust 2004; 181: 195-200.
Maple-Brown L, Cunningham J, Dunne K, et al.
Complications of diabetes in urban Indigenous
Australians: the DRUID study. Diabetes Res Clin
Pract 2008; 80: 455-462.

16 Bryant W, Greenfield JR, Chisholm DJ, Campbell

17

18

19

20

21

22

23

24

LV. Diabetes guidelines: easier to preach than to
practise? Med J Aust 2006; 185: 305-309.
National Association of Diabetes Centres.
Australian national diabetes information audit
and benchmarking: final report ANDIAB 2009.
Canberra, 2009. http://www.health.gov.au/
internet/main/publishing.nsf/Content/pqdiabetes-pubs-andiab09 (accessed Sep 2011).
Kemp TM, Barr EL, Zimmet PZ, et al. Glucose,
lipid, and blood pressure control in Australian
adults with type 2 diabetes: the 1999-2000
AusDiab. Diabetes Care 2005; 28: 1490-1492.
Zwar NA, Hermiz O, Comino EJ, et al. Do
multidisciplinary care plans result in better care
for patients with type 2 diabetes? Aust Fam
Physician 2007; 36: 85-89.
National Association of Diabetes Centres.
Australian national diabetes information audit
and benchmarking: final report ANDIAB 2006.
Canberra, 2007. http://www.health.gov.au/
internet/main/publishing.nsf/Content/pqdiabetes-pubs-andiab06 (accessed Sep 2011).
Aboriginal Medical Services Alliance of the
Northern Territory. OATSIH reporting reforms:
reporting of national key performance indicators
(nKPIs). 2011. http://www.amsant.org.au/
documents/article/94/factsheet5_
reportingnKPIs.pdf (accessed Aug 2012).
Department of Health and Ageing. History of key
MBS primary care initiatives 1999–2010. http://
www.health.gov.au/internet/main/publishing.
nsf/Content/mbsprimarycare-History (accessed
Jul 2012).
National Aboriginal Community Controlled
Health Organisation. Pharmaceutical access.
http://www.naccho.org.au/activities/
pharmaceutical.html (accessed Jul 2012).
Hoy WE, Kondalsamy-Chennakesavan SN, Nicol
JL. Clinical outcomes associated with changes in
a chronic disease treatment program in an
Australian Aboriginal community. Med J Aust
❏
2005; 183: 305-309.

